Almost 300,000 women will be offered a drug to reduce their risk of developing breast cancer, NHS officials have announced.
Some 289,000 post-menopausal women in England who are deemed to have a moderate or high risk of breast cancer will be offered anastrozole in a bid to prevent them from developing the disease.
